Aortofemoral Graft Infection

  • Christopher P. Gibbons

Case Report

A 66-year-old man, an ex-smoker with hypertension and hypercholesterolaemia, had undergone a Dacron bifurcated aortic graft and bilateral ureteric stents for an inflammatory aortic aneurysm with ureteric obstruction at another hospital 4 years previously. The left limb of the graft had been anastomosed to the common femoral artery and the right limb to the common iliac bifurcation. Postoperatively he had suffered a mild groin wound infection, which had healed with antibiotics. At follow-up he complained of left calf and thigh claudication. On examination, he appeared generally well with a midline abdominal scar and a left vertical groin scar. He had good right femoral pulse but an absent left femoral pulse.

Question 1

What should be the first investigation?
  1. A.

    Intra-arterial digital subtraction angiography (DSA).

  2. B.

    Duplex ultrasound scan of the aortic graft.

  3. C.

    99Technetium-labelled leucocyte scan.

  4. D.

    CT angiography of the graft.

  5. E.

    Erythrocyte sedimentation rate...


  1. 1.
    Seeger JM. Management of patients with prosthetic graft infection. Am Surg. 2000;66:166–7.PubMedGoogle Scholar
  2. 2.
    Yeager RA, Porter JM. Arterial and prosthetic graft infection. Ann Vasc Surg. 1992;5:485–91.Google Scholar
  3. 3.
    Naylor AR, Hayes PD, Darke S, on behalf of the Joint Vascular Research Group. A prospective audit of complex wound and graft infections in Great Britain and Ireland: the emergence of MRSA. Eur J Vasc Endovasc Surg. 2001;21:289–94.CrossRefPubMedGoogle Scholar
  4. 4.
    Nasim A, Thompson MM, Naylor AR, et al. The impact of MRSA on vascular surgery. Eur J Vasc Endovasc Surg. 2001;22:211–4.CrossRefPubMedGoogle Scholar
  5. 5.
    Murphy GJ, Pararajasingam R, Nasim A, et al. Methicillin-resistant Staphylococcus aureus infection in vascular surgical patients. Ann R Coll Surg Engl. 2001;83:158–63.PubMedPubMedCentralGoogle Scholar
  6. 6.
    Selan L, Pasariello C. Microbiological diagnosis of aortofemoral graft infections. Eur J Vasc Endovasc Surg. 1997;14(Suppl A):10–2.CrossRefPubMedGoogle Scholar
  7. 7.
    Hicks RJC, Greenhalgh RM. The pathogenesis of vascular graft infection. Eur J Vasc Endovasc Surg. 1997;14(Suppl A):5–9.CrossRefPubMedGoogle Scholar
  8. 8.
    Orton DF, LeVeen RF, Saigh JA, et al. Aortic prosthetic graft infections: radiologic manifestations and implications for management. Radiographics. 2000;20:977–93.CrossRefPubMedGoogle Scholar
  9. 9.
    Spartera C, Morettini G, Petrassi C, et al. Role of magnetic resonance imaging in the evaluation of aortic graft healing, perigraft fluid collection, and graft infection. Eur J Vasc Surg. 1990;4:69–73.CrossRefPubMedGoogle Scholar
  10. 10.
    Liberatore M, Iurilli AP, Ponzo F, et al. Aortofemoral graft infection: the usefulness of 99mTc-HMPAO-labelled leucocyte scan. Eur J Vasc Endovasc Surg. 1997;14(Suppl A):27–9.CrossRefPubMedGoogle Scholar
  11. 11.
    Almgren B, Eriksson I. Local antibiotic irrigation in the treatment of arterial graft infections. Acta Chir Scand. 1981;147:33–6.PubMedGoogle Scholar
  12. 12.
    Morris GE, Friend PJ, Vassallo DJ, et al. Antibiotic irrigation and conservative surgery for major aortic graft infection. Vasc Surg. 1994;20:88–95.CrossRefGoogle Scholar
  13. 13.
    Voboril R, Weberova J, Kralove H. Successful treatment of infected vascular prosthetic grafts in the groin using conservative therapy with povidone-iodine solution. Ann Vasc Surg. 2004;18:372–5.CrossRefPubMedGoogle Scholar
  14. 14.
    Nielsen OM, Noer HH, Jorgensen LG, Lorentzen JE. Gentamicin beads in the treatment of localised vascular graft infection – long term results in 17 cases. Eur J Vasc Surg. 1991;5:283–5.CrossRefPubMedGoogle Scholar
  15. 15.
    Holdsworth J. Treatment of infective and potentially infective complications of vascular bypass grafting using gentamicin with collagen sponge. Ann R Coll Surg Engl. 1999;81:166–70.PubMedPubMedCentralGoogle Scholar
  16. 16.
    Bandyk DF, Novotney ML, Johnson BL, et al. Use of rifampicin-soaked gelatin-sealed polyester grafts for in situ treatment of primary aortic and vascular prosthetic infections. J Surg Res. 2001;95:44–9.CrossRefPubMedGoogle Scholar
  17. 17.
    Naylor AR. Aortic prosthetic infection. Br J Surg. 1999;86:435–6.CrossRefPubMedGoogle Scholar
  18. 18.
    Hayes PD, Nasim A, London NJM, et al. In situ replacement of infected aortic grafts with rifampicin-bonded prostheses: the Leicester experience (1992–1998). J Vasc Surg. 1999;30:92–8.CrossRefPubMedGoogle Scholar
  19. 19.
    Zegelman M, Gunther G. Infected grafts require excision and extra-anatomic reconstruction. Against the motion. In: Greenhalgh RM, editor. The evidence for vascular and endovascular reconstruction. London: WB Saunders; 2002. p. 252–8.Google Scholar
  20. 20.
    Batt M, Magne JL, Alric P, et al. In situ revascularization with silver-coated polyester grafts to treat aortic infection: early and midterm results. J Vasc Surg. 2003;38:983–9.CrossRefPubMedGoogle Scholar
  21. 21.
    Hardman S, Cope A, Swann A, et al. An in vitro model to compare the antimicrobial activity of silver-coated versus rifampicin-soaked vascular grafts. Ann Vasc Surg. 2004;18:308–13.CrossRefPubMedGoogle Scholar
  22. 22.
    Sardelic F, Ao PY, Taylor DA, Fletcher JP. Prophylaxis against Staphylococcus epidermidis vascular graft infection with rifampicin-soaked, gelatin-sealed Dacron. Cardiovasc Surg. 1996;4:389–92.CrossRefPubMedGoogle Scholar
  23. 23.
    Earnshaw JJ, Whitman B, Heather BP, on behalf of the Joint Vascular Research Group. Two-year results of a randomized controlled trial of rifampicin-bonded extra-anatomic Dacron grafts. Br J Surg. 2000;87:758–9.CrossRefPubMedGoogle Scholar
  24. 24.
    Vogt PR, Brunner-LaRocca HP, Lachat M, et al. Technical details with the use of cryopreserved arterial allografts for aortic infection: influence on early and midterm mortality. J Vasc Surg. 2002;35:80–6.CrossRefPubMedGoogle Scholar
  25. 25.
    Verhelst R, Lacroix V, Vraux H, et al. Use of cryopreserved arterial homografts for management of infected prosthetic grafts: a multicentre study. Ann Vasc Surg. 2000;14:602–7.CrossRefPubMedGoogle Scholar
  26. 26.
    Noel AA, Gloviczki P, Cherry KJ Jr. United States cryopreserved aortic allograft registry. Abdominal aortic reconstruction in infected fields: early results of the United States cryopreserved aortic allograft registry. J Vasc Surg. 2002;35:847–52.CrossRefPubMedGoogle Scholar
  27. 27.
    Teebken OE, Pichlmaier MA, Brand S, et al. Cryopreserved arterial allografts for in situ reconstruction of infected arterial vessels. Eur J Vasc Endovasc Surg. 2004;27:597–602.CrossRefPubMedGoogle Scholar
  28. 28.
    Gabriel M, Pukacki F, Dzieciuchowicz L, et al. Cryopreserved arterial allografts in the treatment of prosthetic graft infections. Eur J Vasc Endovasc Surg. 2004;27:590–6.CrossRefPubMedGoogle Scholar
  29. 29.
    Kieffer E, Gomes D, Chiche L, et al. Allograft replacement for infrarenal aortic graft infection: early and late results in 179 patients. J Vasc Surg. 2004;39:1009–17.CrossRefPubMedGoogle Scholar
  30. 30.
    Quinones-Baldrich WJ, Hernandez JJ, Moore WS. Long-term results following surgical management of aortic graft infection. Arch Surg. 1991;126:507–11.CrossRefPubMedGoogle Scholar
  31. 31.
    Yeager RA, Taylor LM Jr, Moneta GL, et al. Improved results with conventional management of infrarenal aortic infection. J Vasc Surg. 1999;30:76–83.CrossRefPubMedGoogle Scholar
  32. 32.
    Seeger JM, Pretus HA, Welborn MB, et al. Long-term outcome after treatment of aortic graft infection with staged extra-anatomic bypass grafting and aortic graft removal. Surgery. 2000;32:451–9.Google Scholar
  33. 33.
    Clagett GP, Valentine RJ, Hagino RT. Autogenous aortoiliac/femoral reconstruction from superficial femoral-popliteal veins: feasibility and durability. J Vasc Surg. 1997;25:255–70.CrossRefPubMedGoogle Scholar
  34. 34.
    Gordon LL, Hagino RT, Jackson MR, et al. Complex aortofemoral prosthetic infections: the role of autogenous superficial femoropopliteal vein reconstruction. Arch Surg. 1999;134:615–21.CrossRefPubMedGoogle Scholar
  35. 35.
    Nevelsteen A, Lacroix H, Suy R. Autogenous reconstruction with lower extremity deep veins: an alternative treatment of prosthetic infection after reconstructive surgery for aortoiliac disease. J Vasc Surg. 1995;22:129–34.CrossRefPubMedGoogle Scholar
  36. 36.
    Daenens K, Fourneau I. Nevelsteen a ten-year experience in autogenous reconstruction with the femoral vein in the treatment of aortofemoral prosthetic infection. Eur J Vasc Endovasc Surg. 2003;25:240–5.CrossRefPubMedGoogle Scholar
  37. 37.
    Brown PM, Kim VB, Lalikos JF, et al. Autologous superficial femoral vein for aortic reconstruction in infected fields. Ann Vasc Surg. 1999;13:32–6.CrossRefPubMedGoogle Scholar
  38. 38.
    Gibbons CP, Ferguson CJ, Fligelstone LJ, Edwards K. Experience with femoro-popliteal veins as a conduit for vascular reconstruction in infected fields. Eur J Vasc Endovasc Surg. 2003;25:424–31.CrossRefPubMedGoogle Scholar
  39. 39.
    Coburn M, Ashworth C, Francis W, et al. Venous stasis complications of the use of the superficial femoral and popliteal veins for lower extremity bypass. J Vasc Surg. 1993;17:1005–9.CrossRefPubMedGoogle Scholar
  40. 40.
    Wells JK, Hagino RT, Bargmann KM, et al. Venous morbidity after superficial femoral-popliteal vein harvest. J Vasc Surg. 1999;29:282–91.CrossRefPubMedGoogle Scholar
  41. 41.
    Modrall JG, Sadjadi J, Ali AT, et al. Deep vein harvest: predicting need for fasciotomy. J Vasc Surg. 2004;39:387–94.CrossRefPubMedGoogle Scholar
  42. 42.
    Nevelsteen A, Baeyens I, Daenens K, et al. Regarding “Deep vein harvest: predicting need for fasciotomy”. J Vasc Surg. 2004;40:403.CrossRefPubMedGoogle Scholar
  43. 43.
    Becquemin JP, Qvarfordt P, Kron J, et al. Aortic graft infection: is there a place for partial graft removal? Eur J Vasc Endovasc Surg. 1997;14(Suppl A):53–8.CrossRefPubMedGoogle Scholar
  44. 44.
    Sladen JG, Thompson RP, Brosseuk DT, Kalman PG, Petrasek PF, Martin RD. Sartorius myoplasty in the treatment of exposed arterial grafts. Cardiovasc Surg. 1993;1:113–7.PubMedGoogle Scholar
  45. 45.
    Galland RB. Sartorius transposition in the management of synthetic graft infection. Eur J Vasc Endovasc Surg. 2002;23:175–7.CrossRefPubMedGoogle Scholar
  46. 46.
    Gomes MN, Spear SL. Pedicled muscle flaps in the management of infected aortofemoral grafts. Cardiovasc Surg. 1994;2:70–7.PubMedGoogle Scholar
  47. 47.
    Thomas WO, Parry SW, Powell RW, et al. Management of exposed inguinofemoral arterial conduits by skeletal muscular rotational flaps. Am Surg. 1994;60:872–80.PubMedGoogle Scholar
  48. 48.
    Meland NB, Arnold PG, Pairolero PC, Lovich SF. Muscle-flap coverage for infected peripheral vascular prostheses. Plast Reconstr Surg. 1994;93:1005–11.CrossRefPubMedGoogle Scholar
  49. 49.
    Calligaro KD, Veith FJ, Sales CM, et al. Comparison of muscle flaps and delayed secondary intention wound healing for infected lower extremity arterial grafts. Ann Vasc Surg. 1994;8:31–7.CrossRefPubMedGoogle Scholar
  50. 50.
    Illig KA, Alkon JE, Smith A, Rhodes JM, et al. Rotational muscle flap closure for acute groin wound infections following vascular surgery. Ann Vasc Surg. 2004;18:661–8.CrossRefPubMedGoogle Scholar
  51. 51.
    Colwell AS, Donaldson MC, Belkin M, Orgill DP. Management of early groin vascular bypass graft infections with sartorius and rectus femoris flaps. Ann Plast Surg. 2004;52:49–53.CrossRefPubMedGoogle Scholar
  52. 52.
    Morasch MD, Sam AD 2nd, Kibbe MR, et al. Early results with use of gracilis muscle flap coverage of infected groin wounds after vascular surgery. J Vasc Surg. 2004;39:1277–83.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  • Christopher P. Gibbons
    • 1
  1. 1.Department of Vascular SurgeryMorriston HospitalSwanseaUK

Personalised recommendations